lixirs or solutions were developed which were capable of treating baldness with proven results.
During the 1970s, researchers at the Upjohn Company noticed that Loniten, a drug used in the treatment of high blood pressure, was causing subjects to grow hair on their heads, as well as on their foreheads and upper cheeks (Folkenberg 9). These researchers developed a new solution using minoxidil, the active ingredient in Loniten, with the hope that it might enhance hair growth in balding men. As a result of this research, Upjohn came up with the product Rogaine. Rubbed on the scalp twice a day, Rogaine with minoxidil apparently "stimulates blood flow and the production of new cells in the scalp" ("Baldness Drug Gets A Boost" 14). In 1983, the Upjohn Company tested the new drug on 2,300 subjects in 27 medical centers across the United States. The study indicated that some men experienced some degree of renewed hair growth after a period of only four months (Folkenberg 9). However, the study also indicated that minoxidil was not effective in treating all cases of baldness. In this regard, the Upjohn study showed that the drug works best on young men who have just begun to lose their hair ("RX For Baldness" 88). In addition, the study showed that minoxidil is only effective in treating baldness on the crown of the head. Thus, "it rarely grows hair on the receding hairline and doesn't grow hair at the temples" (Folkenberg 9). It has been noted that minoxidil will not stimulate new hair growth for people whose hair loss is caused by disease or by the use of medications ("RX For Baldness" 88). Furthermore, although some women were included in the 1983 Upjohn st
...